Identification of key regulators of hepatitis C virus-induced hepatocellular carcinoma by integrating whole-genome and transcriptome sequencing data
G Chen, W Zhang, Y Ben - Frontiers in genetics, 2021 - frontiersin.org
Background: Hepatitis C virus (HCV) infection is a major cause of cirrhosis and
hepatocellular carcinoma (HCC). Despite recent advances in the understanding of the …
hepatocellular carcinoma (HCC). Despite recent advances in the understanding of the …
Interleukin-18 and vascular endothelial growth factor as predictors for end-stage renal disease
AH A El-Khayat, AF A Makled… - Menoufia Medical …, 2018 - menoufia-med-j.com
Objective The objective of this study was to evaluate the role of interleukin-18 (IL-18) and
vascular endothelial growth factor (VEGF) in end-stage renal disease (ESRD), and the …
vascular endothelial growth factor (VEGF) in end-stage renal disease (ESRD), and the …
[PDF][PDF] Journal Homepage:-www. journalijar. com
G Esmat, KA Khalil, M Abdou, F Mustafa, A Salem… - researchgate.net
Aim: to identify the effect of hepatitis C virus treatment by pegylated interferon and ribavirin
on the level of angiogenic factor (Angiopoetin-2 and its receptor Tie-2) and detection of their …
on the level of angiogenic factor (Angiopoetin-2 and its receptor Tie-2) and detection of their …